Dickinson Andrew D 4

What Happened
Andrew D. Dickinson, Chief Financial Officer of Gilead Sciences (GILD), was reported as acquiring 11,090 shares on 2026-02-27. The transaction is coded as an award/acquisition (A) and the filing reports an acquisition price of $0 — these were performance share award tranches that vested upon certification by the Compensation and Talent Committee.

Key Details

• Transaction date: 2026-02-27; Filed: 2026-03-02 (filing appears timely).
• Transaction type/code: Award/Acquisition (A).
• Shares acquired: 11,090 common shares; reported acquisition price: $0.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnote: The shares were part of performance share awards granted March 10, 2025; these tranches required both performance and service vesting. The performance vesting requirement was certified on the reported date (see footnote F1).

Context
This was the vesting and delivery of previously granted performance-based shares, not an open-market purchase or sale. The $0 acquisition price reflects that the shares were issued upon vesting rather than bought by the insider. Such awards are common compensation events and do not, by themselves, indicate a buy or sell decision by the insider.